Stress significantly impacts skin health, potentially triggering conditions like acne, eczema, and psoriasis. Stress hormones ...

Skin is more than a reflection in the mirror it’s the largest organ of your body, toiling away to shield you from the outside ...

Nektar Therapeutics shares jumped 35.3% in extended trading Monday after the company said it would release topline results ...

Nektar Therapeutics said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin on Tuesday. Shares climbed 27% to $12.15 in after-hours trading Monday.

Shares of Nektar Therapeutics soared after the company said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin. The stock was up 31% at $12.49 in Monday's ...

Investing.com -- Nektar Therapeutics (NASDAQ: NKTR) stock surged 20% following the company’s announcement that it will present top-line data from its REZOLVE-AD Phase 2b clinical trial for atopic ...

The FDA pushed back the Prescription Drug User Fee Act action date for ruxolitinib cream (Opzelura) by three months to September 19, 2025. The extension will allow regulators time to review additional ...

The board of directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, in accordance with the intention published by ...

A new study published in the Journal of American Medical Association showed that dupilumab (Dupixent), used for treating ...

A team led by the University of Exeter, and including researchers from King's College London, has been awarded a £3.3 million grant from the Medical ...

FDA extends review of Incyte's ruxolitinib cream for children with atopic dermatitis, delaying decision to September 2025.

Shea butter has historically been used for skin ailments for centuries. Learn the wide range of shea butter benefits and how ...